Splicing abnormalities caused by a novel mutation in the PHKA2 gene in children with glycogen storage disease type IX.
10.3760/cma.j.cn501113-20220120-00034
- Author:
Zhi Hua ZHANG
1
;
Bi Xia ZHENG
2
;
Yu Jie ZHUO
1
;
Yu JIN
1
;
Zhi Feng LIU
1
;
Yu Can ZHENG
1
Author Information
1. Department of Gastroenterology, Children's Hospital of Nanjing Medical University, Nanjing 210008, China.
2. Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing 210008, China.
- Publication Type:Journal Article
- Keywords:
Aberrant RNA splicing;
Glycogen storage disease type IX;
Next-generation panel sequencing;
PHKA2 gene
- MeSH:
Child;
Humans;
Exons;
Glycogen Storage Disease/genetics*;
Hepatomegaly/genetics*;
Mutation;
Phosphorylase Kinase/genetics*;
Male;
Female
- From:
Chinese Journal of Hepatology
2023;31(4):428-432
- CountryChina
- Language:Chinese
-
Abstract:
Objective: Glycogen storage disease type IX (GSD-IX) is a rare primary glucose metabolism abnormality caused by phosphorylase kinase deficiency and a series of pathogenic gene mutations. The clinical characteristics, gene analysis, and functional verification of a mutation in a child with hepatomegaly are summarized here to clarify the pathogenic cause of the disease. Methods: The clinical data of a child with GSD-IX was collected. Peripheral blood from the child and his parents was collected for genomic DNA extraction. The patient's gene diagnosis was performed by second-generation sequencing. The suspected mutations were verified by Sanger sequencing and bioinformatics analysis. The suspected splicing mutations were verified in vivo by RT-PCR and first-generation sequencing. Results: Hepatomegaly, transaminitis, and hypertriglyceridemia were present in children. Liver biopsy pathological examination results indicated glycogen storage disease. Gene sequencing revealed that the child had a c.285 + 2_285 + 5delTAGG hemizygous mutation in the PHKA2 gene. Sanger sequencing verification showed that the mother of the child was heterozygous and the father of the child was of the wild type. Software such as HSF3.1 and ESEfinder predicted that the gene mutation affected splicing. RT-PCR of peripheral blood from children and his mother confirmed that the mutation had caused the skipping of exon 3 during the constitutive splicing of the PHKA2 gene. Conclusion: The hemizygous mutation in the PHKA2 gene (c.285 + 2_285 + 5delTAGG) is the pathogenic cause of the patient's disease. The detection of the novel mutation site enriches the mutation spectrum of the PHKA2 gene and serves as a basis for the family's genetic counseling.
